Veerle Bergink, MD, PhD, Director of Mount Sinai’s Women’s Mental Health Program
Veerle Bergink, MD, PhD, director of Mount Sinai’s Women’s Mental Health Program, and researchers at the Center for Register-based Research at Aarhus University have found that there were no changes in the likelihood of developing neurodevelopmental disorders among children exposed to ADHD medication in utero. This study is the first to examine in utero exposure to stimulants and long term child outcomes. Researchers examined almost 900 children who were exposed to ADHD during the mothers’ pregnancy and 1270 children who were not.